Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help.
about
Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopesThe regression of a canine Langerhans cell tumour is associated with increased expression of IL-2, TNF-alpha, IFN-gamma and iNOS mRNAExtracellular HSPs: The Complicated Roles of Extracellular HSPs in ImmunityPathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell VaccinationAlloantibody Generation and Effector Function Following Sensitization to Human Leukocyte AntigenThe Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell GenerationAcute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis.Antigen presentation and the regulation of CD4 memory generation to influenza.CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLsCD70 expression by dendritic cells plays a critical role in the immunogenicity of CD40-independent, CD4+ T cell-dependent, licensed CD8+ T cell responsesRole of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity.Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expressionLongitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses.Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaquesEngineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential.Cell-based vaccines for the stimulation of immunity to metastatic cancers.The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo.An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.CD4+ T cells modulate expansion and survival but not functional properties of effector and memory CD8+ T cells induced by malaria sporozoitesResistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigen.Oral administration of antigen can lead to the onset of autoimmune disease.CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells.Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancerRole of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection.Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses.CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.CD8(+) T-cell priming against a nonsecreted Listeria monocytogenes antigen is independent of the antimicrobial activities of gamma interferon.Contribution of CD8(+) T cells to gamma interferon production in human tuberculosis.Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein.CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity.New methods for assessing T-cell responses.Transplantation tolerance: from theory to clinic.Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation.Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells.β-defensin 2 as an adjuvant promotes anti-melanoma immune responses and inhibits the growth of implanted murine melanoma in vivo.Dendritic cells and immunotherapy for malignant disease.Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions
P2860
Q24674180-9BBEAFF7-A29F-4035-A4DA-00E3602E4B13Q24682924-D811CCF0-78FC-4AA8-9578-D9841E280657Q26747413-6EEB7FA5-FA38-4E04-BF91-76A9F04807EEQ26765345-CAB3E895-4DA1-4268-B7B2-A13A51606694Q26766411-98C6EAD3-FCF6-40F4-912D-4315F9CCB97CQ26797344-C78839B9-BA03-4DDD-B957-5823B8AADB6CQ30275560-085012ED-64D9-44E8-BB76-68DDB6CC224CQ30276224-6526DD8D-0F5D-4104-A16E-14DAC033FF75Q30389279-FA139BEE-AF8E-40CC-9CDB-9B18BF07996AQ30430530-B5351A75-3DEA-4F04-B8B0-34C990D3E199Q30433070-EA7F05AD-07D7-4830-9C23-7F1738886F5EQ30769959-D65FF5FC-1B66-41A2-961C-2AB8C62E5D5AQ33486534-F09C72AB-7A39-4DFD-B9FA-16CE73D1433FQ33630150-9C814D8D-41E0-4C9E-B0A5-DE4FCAEB9E3AQ33648495-F1C48306-3097-492A-96C9-DDD3620775DCQ33698112-03DEA8A8-F7EA-4331-97D0-94A4EE7EFA35Q33720359-67F52ED5-C508-4528-9B6A-9122160A491CQ33776134-232574A9-02C3-4C15-B4C4-8D7508A1FB86Q33778844-EE9EA1CE-AA55-4671-925D-41C0DDE2A9ADQ33788131-2DE5E3F7-930B-4710-9D93-29852626EAC5Q33796468-F2E47A88-BE3A-4D00-9ED2-B5EBC4F11B8CQ33798154-53938633-11BC-4158-8D9C-77A7C4CFCC82Q33805860-21F0743B-D6B5-4706-A811-0BDB2B45D703Q33810726-6F64E302-5934-4CEB-AD45-D51F4C4414E5Q33815011-4B10C194-42E2-43C6-86DD-F76E00C4280EQ33835246-2420623C-60BB-43DF-9C5B-E1E9B6B9BDD0Q33849973-39CF0AC1-93C0-4DD0-9F6F-365E0DD742CAQ33928441-563E3BC3-5BB0-42E4-A6C5-FFFE364D8E75Q34003973-10C74085-50EB-436D-B38A-B82F51B9A48CQ34007470-F2EA4ADA-D258-4AFF-A665-4DBD1A9931B4Q34008526-5009F904-1ABA-4305-859D-F4546B4F40F2Q34025520-683DFF74-7C18-41A9-96F5-2C0BBD929B21Q34076691-6D2054F6-5127-4347-B4D1-D78DDCE58760Q34082059-10892EDB-48CC-4E3F-B7B3-47C997502DBBQ34103866-D66C4F42-BFE2-4A34-8EE3-7AE60CCAB0AAQ34119135-071ED59F-A12B-424B-81DC-6FDB9B05E055Q34161849-737C6745-4CE5-45A1-9BDD-97A87DEB4CFCQ34163480-8488A873-F4D0-484F-85B3-BB4DBE2C338FQ34216506-A4597AD7-2FD6-4129-8B46-CFDB309DFDE7Q34339686-AA0C1A87-E376-44B1-9790-728AF5EFCA56
P2860
Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Induction of a CD8+ cytotoxic ...... ires cognate CD4+ T cell help.
@ast
Induction of a CD8+ cytotoxic ...... ires cognate CD4+ T cell help.
@en
type
label
Induction of a CD8+ cytotoxic ...... ires cognate CD4+ T cell help.
@ast
Induction of a CD8+ cytotoxic ...... ires cognate CD4+ T cell help.
@en
prefLabel
Induction of a CD8+ cytotoxic ...... ires cognate CD4+ T cell help.
@ast
Induction of a CD8+ cytotoxic ...... ires cognate CD4+ T cell help.
@en
P2093
P2860
P356
P1476
Induction of a CD8+ cytotoxic ...... ires cognate CD4+ T cell help.
@en
P2093
F Karamalis
F R Carbone
J F Miller
S R Bennett
P2860
P356
10.1084/JEM.186.1.65
P407
P577
1997-07-01T00:00:00Z